Clough Capital Partners is a global multi-strategy alternative asset management firm based in Boston, MA. The firm employs fundamental research to invest in public and private markets across various asset classes. While specific investment stages are not detailed, Clough Capital's portfolio includes investments in Series C and Series E rounds, indicating a focus on later-stage ventures. Their diverse investment strategies encompass global long and short strategies, healthcare long and short strategies, and healthcare late-stage venture strategies.
Notable portfolio companies include Amphivena Therapeutics, Apellis Pharmaceuticals, and Elcelyx Therapeutics. Clough Capital's key partners bring extensive experience from various sectors, enhancing their investment decisions. The firm emphasizes a research-driven approach to identify high-potential opportunities. Additionally, Clough Capital offers unique value-add services such as strategic guidance and operational support to help portfolio companies scale effectively.
Clough Capital Partners - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Top Investment Stages
Stage Mix

Clough Capital: A diversified asset management firm offering strategic investment in public and private markets.
Concentration shown as share of disclosed investments by stage.
Clough Global Equity Fund

Aphelion Capital

Clover Capital Partners
clovercp.com

Cloquet Capital Partners
cloquetcapital.com

PAR Capital Management
parcapital.com
Clayton Associates
Claflin Capital Management
claflincapital.com

Clarion Capital Partners

Clarity Partners
Healthcare Ventures
hcven.com

Clarke Capital Partners
clarkecp.com

The Capital Partnership
tcpam.com
Epiphron Capital
Commonwealth Capital Ventures
commonwealthvc.com

Closed Loop Capital